Abstract
The detailed molecular characterization of lethal cancers is a prerequisite to understanding resistance to therapy and escape from cancer immunoediting. We performed extensive multi-platform profiling of multi-regional metastases in autopsies from 10 patients with therapy-resistant breast cancer. The integrated genomic and immune landscapes show that metastases propagate and evolve as communities of clones, reveal their predicted neo-antigen landscapes, and show that they can accumulate HLA loss of heterozygosity (LOH). The data further identify variable tumor microenvironments and reveal, through analyses of T cell receptor repertoires, that adaptive immune responses appear to co-evolve with the metastatic genomes. These findings reveal in fine detail the landscapes of lethal metastatic breast cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 2690-2708.e10 |
| Journal | Cell Reports |
| Volume | 27 |
| Issue number | 9 |
| DOIs | |
| State | Published - 28 May 2019 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019 The Authors
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- breast cancer
- clade mutations
- genomic landscapes
- immune landscapes
- immunoediting
- metastases
- metastatic phylogenies
- private mutations
- stem mutations
- TCR repertoire
Fingerprint
Dive into the research topics of 'The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver